Nanopat: You clearly show that in '08 USAMRIID thought the results showed highly effective results in cell cultures, and then in '10 they were not as effective in mice.
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that the broad-spectrum nanoviricides(TM) drug candidates were found to be highly effective against the deadly Ebola virus in initial cell culture studies by scientists at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).
in '10: The compounds were well tolerated by the animals and showed some efficacy against the mouse-adapted Ebola virus.
The choice of highly and some is actually a scientific delineation. Sounds pretty imprecise I know.
They're going in the wrong direction. But let's talk more about EBOLA and not about TOx not being started, and the company not being able to determine how much material they can make in a week at the existing facility.
What will the next delay be?
Prediction: EBOLA is now such a big opportunity, they are using material that WAS going to be used for Flu Tox to EBOLA. This will be for "humanitarian" reasons and because it would be foolish not to take advantage of this current "crisis."